Dr. Hönle AG: Hönle Group confirms positive operating result for financial year 2023/24, but special effects impact EBIT

Gilching (pta014/21.11.2024/10:15) - The Management Board forecasted sales of around €100 million and a positive operating result (EBIT) for the Hönle Group for the 2023/24 financial year. Based on current knowledge, the Management Board assumes that the Hönle Group achieved a positive operating result (adjusted EBIT) in the 2023/24 financial year with sales of around €98 million.

As part of the strategic realignment of the corporate group, focus and growth areas were defined and it was decided to no longer serve application areas that are not part of the core business. This will likely involve adjustments to the book value of goodwill and inventories, which will have a one-off impact on the operating result in the 2023/24 financial year of about €10 million.

All information is unaudited. As planned, Dr. Hönle AG will publish preliminary figures for the past financial year and the outlook for the new 2024/25 financial year on December 6, 2024. The 2023/24 annual report will be published on January 30, 2025.

About Hönle

The Dr. Hönle AG is a listed technology company based in Gilching. The Hönle Group develops innovative solutions for a wide range of industrial applications with its 600 employees. A focus of the company's business activities is the development and sale of industrial adhesives and adhesive curing devices. The company also produces drying systems for the printing and coating industry. Another business area deals with the environmentally friendly disinfection of water, air and surfaces. The Hönle Group supplies technology and global market leaders worldwide and is represented in over 20 countries with its own companies and partner companies.

(Ende)